Everything you want to know, and not afraid to ask: The evidence, the how, and the challenges.
The optimization of GDMT in the treatment of HF has been shown to reduce morbidity and mortality, and improve patient outcomes. However, many HF patients do not receive GDMT and/or achieve the recommended target dose of their medications. Studies have shown that while most patients are managed by cardiologists or primary care practitioners, GDMT and target doses of medication can also be successfully achieved by expanding this role to other providers. Education on GDMT, optimizing medications, and these successful strategies are needed to expand patient outcomes. This program will provide practitioners with updated information on the universal definition of heart failure, guideline-directed medical therapies (GDMT), and strategies that optimize medical therapies (OMT) to improve patient outcomes.
This program is intended for physicians, nurses, nurse practitioners, physician assistants, and advanced practice professionals that provide care to patients with heart failure.
At the end of this educational session, the learner will be able to:
- Identify evidence-based therapies that improve outcomes in HF management
- Recognize and discuss clinical and socio-economic barriers to implementing GDMT to achieve therapeutic success and improve patient outcomes
- Develop strategies to successfully manage the clinical barriers (comorbidities) of implementing GDMT
All sessions are listed in Eastern Standard Time.
Welcome and Introduction
Guideline-Directed Medical Therapy (GDMT): Evidence and Benefits and Live Q&A
Larry A. Allen, MD, MHS
Tearing Down the Barriers to Optimizing GDMT: Considerations in the Patient with Heart Failure and Live Q&A
Robert L. Page II, PharmD, MSPH, FHFSA, FAHA, FCCP
Personalizing Therapy for the Tough Cases and Strategies for Navigating Comorbidities Which Become Barriers to Success and Live Q&A
Lynne Warner Stevenson, MD, FHFSA
End of Program